Clinical Trials Directory

Trials / Completed

CompletedNCT06946108

Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis

Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis: A Prospective Cohort Investigation Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,101 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pancreatic exocrine insufficiency (PEI) is one of the common complications of chronic pancreatitis (CP). Mild to moderate PEI may present with atypical digestive tract symptoms such as abdominal distension and abdominal pain, while severe PEI can lead to related complications such as foul-smelling stools, steatorrhea, weight loss, and malnutrition. Currently, there is no relevant report on the status quo of PEI in Chinese CP patients. This study aims to analyze the status quo of PEI and related risk factors in Chinese CP patients, with the hope of providing safe and effective intervention and treatment methods to improve the quality of life of patients.

Detailed description

Pancreatic exocrine insufficiency (PEI) is one of the common complications of chronic pancreatitis (CP). Mild to moderate PEI may present with atypical digestive tract symptoms such as abdominal distension and abdominal pain, while severe PEI can lead to related complications such as foul-smelling stools, steatorrhea, weight loss, and malnutrition. Currently, there is no relevant report on the status quo of PEI in Chinese CP patients.This study aims to analyze the current status and related risk factors of PEI in CP patients in China by detecting pancreatic exocrine function with FE-1, in order to provide safe and effective intervention and treatment methods and improve the quality of life of patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDetection of Pancreatic Exocrine Function in Patients with Chronic Pancreatitis (CP)For CP patients who are hospitalized, they are recruited to voluntarily preserve their feces for the detection of fecal elastase-1 (FE-1) so as to evaluate the pancreatic exocrine function.

Timeline

Start date
2022-06-01
Primary completion
2024-09-30
Completion
2024-10-10
First posted
2025-04-27
Last updated
2025-04-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06946108. Inclusion in this directory is not an endorsement.